Sfoglia per Autore
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review
2012 DE ANGELIS, Federico; DI ROCCO, Alice; Clara, Minotti; Valesini, Guido; Claudio, Cartoni; Riminucci, Mara; Conti, Fabrizio; Erica, Finolezzi; Armiento, Daniele; Grammatico, Sara; Massaro, Laura; Fama, Angelo; Colafigli, Gioia; Catrine, Viccarone; Foa, Roberto; Martelli, Maurizio
Corrigendum to "Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept: A case report and literature review" [Leuk. Res. 36 (2012) e199-e201]
2013 De Angelis, Federico; Di Rocco, Alice; Minotti, Clara; Valesini, Guido; Cartoni, Claudio; Riminucci, Mara; Conti, Fabrizio; Finolezzi, Erica; Armiento, Daniele; Grammatico, S.; Massaro, L.; Fama, A.; Colafigli, G.; Viccarone, C.; Foã , R.; Martelli, M.
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells.
2014 Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto
Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy
2015 Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
2015 Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana
Improvement of bone marrow fibrosis with ruxolitinib: Will this finding change our perception of the drug?
2015 Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Alimena, Giuliana
Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib
2015 Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; DE ANGELIS, Federico; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Alimena, Giuliana
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up
2016 Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto
Clinical relevance of silent red blood cell autoantibodies.
2017 Mauro, Fr; Trastulli, F; Alessandri, C; Valesini, G; Giovannetti, G; Riemma, C; Porrazzo, M; Pepe, S; Colafigli, G; Caputo, Md; De Propris, Ms; Guarini, Ar; Girelli, G; Coluzzi, S; Foà, R
Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life
2017 Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Foà, Robin
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
2017 Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villivà, N; Celesti, F; Trawinska, Mm; Massaro, Fulvio; Di Veroli, A; Anaclerico, Barbara; Colafigli, Gioia; Molica, Matteo; Spadea, A; Petriccione, L; Cimino, Giuseppe; Latagliata, R.
Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib.
2017 Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R.
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
2017 Polverelli, Nicola; Breccia, Massimo; Benevolo, Giulia; Martino, Bruno; Tieghi, Alessia; Latagliata, Roberto; Sabattini, Elena; Riminucci, Mara; Godio, Laura; Catani, Lucia; Nicolosi, Maura; Perricone, Margherita; Sollazzo, Daria; Colafigli, Gioia; Campana, Anna; Merli, Francesco; Vitolo, Umberto; Alimena, Giuliana; Martinelli, Giovanni; Lewis, Russell E.; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
2017 Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M.
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials
2017 Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
2018 Latagliata, Roberto; Breccia, Massimo; Carmosino, Ida; Cesini, Laura; De Benedittis, Daniela; Mohamed, Sara; Vozella, Federico; Molica, Matteo; Campanelli, Melissa; DE LUCA, MARIA LUCIA; Colafigli, Gioia; Quattrocchi, Luisa; Loglisci, MARIA GIOVANNA; Massaro, Fulvio; Canichella, Martina; Diverio, Daniela; Mancini, Marco; Alimena, Giuliana; Robin, Foà
Overall Survival and Response Rates after a 10-Year Follow-up of Chronic Myeloid Leukemia Patients in Chronic Phase Treated with Imatinib in a Real-Life Practice
2018 Molica, Matteo; Scalzulli, Emilia; ALUNNI FEGATELLI, Danilo; Roberto, Latagliata; Colafigli, Gioia; Rizzo, Lorenzo; Daniela, Diverio; Robin, Foà; Breccia, Massimo
Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinib
2018 Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Massaro, Fulvio; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Guarini, Anna; Alimena, Giuliana; Foà, Robin
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events
2018 Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome
2019 Colafigli, Gioia; Scalzulli, Emilia; Porrazzo, Marika; Diverio, Daniela; Loglisci, Maria Giovanna; Latagliata, Roberto; Guarini, Anna; Foa, Robin; Breccia, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review | 2012 | DE ANGELIS, Federico; DI ROCCO, Alice; Clara, Minotti; Valesini, Guido; Claudio, Cartoni; Riminucci, Mara; Conti, Fabrizio; Erica, Finolezzi; Armiento, Daniele; Grammatico, Sara; Massaro, Laura; Fama, Angelo; Colafigli, Gioia; Catrine, Viccarone; Foa, Roberto; Martelli, Maurizio | |
| Corrigendum to "Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept: A case report and literature review" [Leuk. Res. 36 (2012) e199-e201] | 2013 | De Angelis, Federico; Di Rocco, Alice; Minotti, Clara; Valesini, Guido; Cartoni, Claudio; Riminucci, Mara; Conti, Fabrizio; Finolezzi, Erica; Armiento, Daniele; Grammatico, S.; Massaro, L.; Fama, A.; Colafigli, G.; Viccarone, C.; Foã , R.; Martelli, M. | |
| Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells. | 2014 | Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto | |
| Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy | 2015 | Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto | |
| Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront | 2015 | Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana | |
| Improvement of bone marrow fibrosis with ruxolitinib: Will this finding change our perception of the drug? | 2015 | Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Alimena, Giuliana | |
| Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib | 2015 | Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; DE ANGELIS, Federico; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Alimena, Giuliana | |
| Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up | 2016 | Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto | |
| Clinical relevance of silent red blood cell autoantibodies. | 2017 | Mauro, Fr; Trastulli, F; Alessandri, C; Valesini, G; Giovannetti, G; Riemma, C; Porrazzo, M; Pepe, S; Colafigli, G; Caputo, Md; De Propris, Ms; Guarini, Ar; Girelli, G; Coluzzi, S; Foà, R | |
| Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life | 2017 | Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Foà, Robin | |
| Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN. | 2017 | Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villivà, N; Celesti, F; Trawinska, Mm; Massaro, Fulvio; Di Veroli, A; Anaclerico, Barbara; Colafigli, Gioia; Molica, Matteo; Spadea, A; Petriccione, L; Cimino, Giuseppe; Latagliata, R. | |
| Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib. | 2017 | Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R. | |
| Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients | 2017 | Polverelli, Nicola; Breccia, Massimo; Benevolo, Giulia; Martino, Bruno; Tieghi, Alessia; Latagliata, Roberto; Sabattini, Elena; Riminucci, Mara; Godio, Laura; Catani, Lucia; Nicolosi, Maura; Perricone, Margherita; Sollazzo, Daria; Colafigli, Gioia; Campana, Anna; Merli, Francesco; Vitolo, Umberto; Alimena, Giuliana; Martinelli, Giovanni; Lewis, Russell E.; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca | |
| Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. | 2017 | Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M. | |
| The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials | 2017 | Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse? | 2018 | Latagliata, Roberto; Breccia, Massimo; Carmosino, Ida; Cesini, Laura; De Benedittis, Daniela; Mohamed, Sara; Vozella, Federico; Molica, Matteo; Campanelli, Melissa; DE LUCA, MARIA LUCIA; Colafigli, Gioia; Quattrocchi, Luisa; Loglisci, MARIA GIOVANNA; Massaro, Fulvio; Canichella, Martina; Diverio, Daniela; Mancini, Marco; Alimena, Giuliana; Robin, Foà | |
| Overall Survival and Response Rates after a 10-Year Follow-up of Chronic Myeloid Leukemia Patients in Chronic Phase Treated with Imatinib in a Real-Life Practice | 2018 | Molica, Matteo; Scalzulli, Emilia; ALUNNI FEGATELLI, Danilo; Roberto, Latagliata; Colafigli, Gioia; Rizzo, Lorenzo; Daniela, Diverio; Robin, Foà; Breccia, Massimo | |
| Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinib | 2018 | Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Massaro, Fulvio; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Guarini, Anna; Alimena, Giuliana; Foà, Robin | |
| Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events | 2018 | Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome | 2019 | Colafigli, Gioia; Scalzulli, Emilia; Porrazzo, Marika; Diverio, Daniela; Loglisci, Maria Giovanna; Latagliata, Roberto; Guarini, Anna; Foa, Robin; Breccia, Massimo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile